Labshake search
Citations for Tocris :
751 - 800 of 932 citations for 2 Trimethylsilyl Furo 3 2 B Pyridine 6 Carbaldehyde since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biochemistry 2024Quote: ... Exendin-3 (9-39) amide (2081) was purchased from Tocris. Recombinant GDF15 (957-GD ...
-
bioRxiv - Cancer Biology 2023Quote: ... 3 μM of CHIR99021 (Tocris Bioscience, Minneapolis, USA, Cat#4423) and 1 μM of PD0325901 (Selleckchem ...
-
bioRxiv - Developmental Biology 2023Quote: ... The N2B27 medium was supplemented with CHIR (3 μM, Tocris), FGF2 (20 ng/ml ...
-
bioRxiv - Neuroscience 2024Quote: Peptide YY (3-36) (PYY) was obtained from Tocris (#1618) and dissolved in water to achieve a 100µM stock solution ...
-
bioRxiv - Neuroscience 2020Quote: ... Pluripotent hESCs were incubated with small molecules to start the dual SMAD inhibition: BMP and TGF-b receptors were pharmacologically blocked with 100 nM LDN193189 (Stemgent) and 10 mM SB431542 (Tocris), respectively ...
-
bioRxiv - Cell Biology 2022Quote: ... the actin depolymerizer latrunculin B (10 μM; for 30 min only to preserve cell viability; Tocris Bioscience; Thermo Fisher Scientific), or the YAP inhibitor verteporfin (0.5 μM ...
-
bioRxiv - Neuroscience 2023Quote: ... Drug and vehicle solutions were coded as “A” or “B.” CP690550 citrate (tofacitinib citrate) (#4556, Tocris Bioscience, Bristol, United Kingdom) was dissolved in a solution of 70% saline (0.9%)/15% ethanol/15% DMSO ...
-
bioRxiv - Neuroscience 2020Quote: Zebrafish larvae (5–6 dpf) were first paralysed in 1 mM α-Bungarotoxin solution (Tocris) for 3–6 min after which they were pinned in a lateral position to a Sylgard-coated recording dish (Sylgard 184 ...
-
bioRxiv - Neuroscience 2020Quote: ... 6-Cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX disodium salt; Cat. No. 1045, Tocris, UK), DL-2-Amino-5-phosphonopentanoic acid sodium salt (AP5 ...
-
bioRxiv - Neuroscience 2021Quote: ... The solution was PBS-based and included 10-60 mM 6-OHDA hydrochloride (Tocris, 2547), 10 μM l-ascorbic acid (Millipore/Sigma ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were pre-treated for 6 hours with 100 μM CPYPP (DOCK-i; No4568, Tocris). To inhibit Shh signaling ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 µM 6-cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX, Tocris Bioscience, Briston, UK) and 50 µM D-(-)-2-amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Neuroscience 2022Quote: ... 6-N,N-Diethyl-β-γ-dibromomethylene-D-adenosine-5′-triphosphate (ARL 67156; Tocris, 1283) was perfused through the probe at concentrations of 1 mM ...
-
bioRxiv - Animal Behavior and Cognition 2023Quote: ... receiving either eglumetad (6 mg/kg, 10.8 mM; also known as LY-354740, Tocris, UK) or saline vehicle injections ...
-
bioRxiv - Immunology 2023Quote: ... coated 6 cm dishes in mTeSR Plus media with 10 μM Y-27632 (Tocris, 1254). On Day 0 ...
-
bioRxiv - Cell Biology 2023Quote: ... E8 medium was replaced with E6 medium supplemented with 6 uM CHIR99021 (Tocris Bioscience, 4423), 20 ng/mL Bone Morphogenetic Protein 4 (rBMP4 ...
-
bioRxiv - Cell Biology 2021Quote: ... B/D medium was supplemented during submerged culture with 1 nM EC23 (light-stable retinoic acid receptor agonist; Tocris, Abingdon, UK). After confluence was reached ...
-
bioRxiv - Immunology 2020Quote: ... anti-IgM/CpG-activated or non-activated B cells were incubated with or without reserpine (5 μM, Tocris, catalogue number: 2747), an inhibitor of VMAT-1 & VMAT-2 for 45min ...
-
bioRxiv - Cell Biology 2020Quote: ... cells were stained with 3 µg/mL FM4-64 (Tocris 5118) in BY-2 media then imaged with a 560 nm diode-pumped solid-state laser (Melles Griot ...
-
bioRxiv - Neuroscience 2023Quote: ... the NMDA antagonist AP5 (3 μg/0.5 μl/side; Tocris Bioscience) to the DMS ...
-
bioRxiv - Bioengineering 2023Quote: ... or phosphoinositide 3-kinase (PI3K) (LY 294002, 10 µM, Tocris, UK) for 4 days ...
-
bioRxiv - Cell Biology 2023Quote: ... 0.1 mM 8-Bromoadenosine 3′,5′-cyclic monophosphate sodium salt (Tocris) and 0.1 mM 3-Isobutyl-1-methylxanthine (Sigma-Aldrich) ...
-
bioRxiv - Bioengineering 2023Quote: ... A staining solution was prepared with 3 µM Hoechst 33342 (Tocris), 4 µM calcein-AM (eBioscience) ...
-
bioRxiv - Cell Biology 2023Quote: ... 0.1 mM 8-Bromoadenosine 3′,5′-cyclic monophosphate sodium salt (Tocris) and 0.1 mM 3-Isobutyl-1-methylxanthine (Sigma-Aldrich) ...
-
bioRxiv - Neuroscience 2024Quote: ... α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA, Tocris Bioscience), Kainate and N-methyl-D-aspartate acid (NMDA ...
-
bioRxiv - Bioengineering 2020Quote: Ectoderm differentiation was induced using Essential 6 (E6) medium supplemented with LDN-193189 (100 nM, Tocris) and A83-01 (2 μM ...
-
bioRxiv - Neuroscience 2023Quote: ... Firing was recorded for 6 minutes before and after wash in of muscimol (50 μM, Tocris).
-
bioRxiv - Neuroscience 2023Quote: ... or 6-Cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX, 10 μM dissolved in H2O; Tocris Bioscience), or tetrodotoxin (TTX ...
-
bioRxiv - Cell Biology 2024Quote: ... Day 6: The medium was changed with the differentiation medium containing 0.25μM Sant-I (Tocris-#1974), 100ng/mL Noggin (Sino Biological-#10267) ...
-
bioRxiv - Neuroscience 2023Quote: ... either alone or with 10 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, Tocris). Neurons were fixed with 4% PFA and 4% sucrose in PBS for 10 minutes at room temperature ...
-
bioRxiv - Neuroscience 2024Quote: AMPA/kainate glutamate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 20 μM, Tocris Bioscience) and NMDA glutamate receptor antagonist (RS)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid ((RS)-CPP ...
-
bioRxiv - Neuroscience 2021Quote: ... In every animal a volume of 500nl of CNO (3 µM, Tocris) was infused at a rate of 0.5µl/min to target the PAG ...
-
bioRxiv - Genomics 2020Quote: ... ‘‘CBRa’’ medium consists of cSFDM base supplemented with 3 µM CHIR99021 (Tocris), 10 ng/mL recombinant human BMP4 (rhBMP4 ...
-
bioRxiv - Neuroscience 2021Quote: ... we added the CB1 receptor antagonist AM-251 (3 µM; Tocris, UK), or the NO synthase inhibitor L-NAME (200 µM ...
-
bioRxiv - Neuroscience 2020Quote: ... and the glutamate receptor antagonist kynurenic acid (3 mM KynA, Tocris Bioscience) was included in the external solution to isolate GABA currents ...
-
bioRxiv - Neuroscience 2020Quote: ... the IS was supplemented with 3 mg/ml biocytin (Tocris, Bristol, UK) or 1.5 mg/ml neurobiotin (Vector Laboratories ...
-
bioRxiv - Genomics 2021Quote: ... and 12uM of GSK-3 inhibitor CHIR99021 trihydrochloride (4953, Tocris, Bristol, UK). “Heart media” is composed of RPMI (15-040-CM ...
-
bioRxiv - Neuroscience 2022Quote: ... 3 dpf zebrafish were paralysed using α-bungarotoxin (1 mg/ml, Tocris) and embedded in 1.2% low melting point agarose ...
-
bioRxiv - Neuroscience 2022Quote: ... and 3-Deazaneplanocin A hydrochloride (DZN; 1 µg/dose in DMSO; Tocris). Tamoxifen (Sigma ...
-
bioRxiv - Bioengineering 2023Quote: ... A83-01 (PeproTech, cat# 9094360 or Tocris, cat# 2939, 0.1-3 µM) and the impedance of monolayers was measured at 10 kHz at every 5 min for 48-96 h ...
-
bioRxiv - Neuroscience 2023Quote: ... Antagonists included the GABA-A blocker bicuculline methiodide (BCC, 3 μM, Tocris) by itself or ...
-
bioRxiv - Cell Biology 2023Quote: ... Media was then changed to cSFDM with 3 uM CHIR99021 (“C”; Tocris), recombinant human BMP4 (10 ng/ml ...
-
bioRxiv - Cell Biology 2024Quote: ... the Phosphoinositide 3-kinase (PI3K) inhibitor A66 32 nM (Tocris, Bristol, UK), or PI3K stimulator 740Y-P (1 mg/ml ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 μM of 2,3-dihydroxy 6-nitro-7-sulfamoyl-benzoquinoxaline-2,3-dione (NBQX, 1044, Tocris Bioscience, UK), 25 μM of d-(-)-2-amino-5-phosphonopentanoic acid (D-AP5 ...
-
bioRxiv - Neuroscience 2024Quote: ... All networks received a 20-min 50 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, in DMSO; Tocris, #0373) treatment on top of that ...
-
bioRxiv - Neuroscience 2024Quote: ... IPSCs were recorded in the presence of 10µM CNQX (6-cyano-7-nitroquinoxaline-2,3-dione, Tocris 1045) and 50µM D-AP5 (D-2-amino-5-phosphonovalerate ...
-
bioRxiv - Neuroscience 2023Quote: ... to block Na channels or 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM, Tocris, Minneapolis, USA) to block AMPA/kainate receptors were introduced to the standard ACSF.
-
bioRxiv - Neuroscience 2023Quote: The AMPA receptor antagonist cyanquixaline (6-cyano-7-nitroquinoxaline-2,3-dione; CNQX disodium salt; #1045; Tocris Biosciences) or 6,7-Dinitroquinoxaline-2,3(1H,4H)-dione (DNQX disodium salt ...
-
bioRxiv - Cell Biology 2024Quote: ... the media was replaced with RPMI/B27(-ins) containing 7.5 uM of IWP2 (Tocris 686770-61-6), followed by another media change with RPMI/B27(-ins ...
-
bioRxiv - Neuroscience 2024Quote: ... followed by doxycycline induction (6 days) and neural induction by adding SMAD inhibitors SB431542 and XAV939 (Tocris). The medium was supplemented with BDNF (Millipore) ...